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Abstract
Mutations in DNA mismatch repair (MMR) lead to increased mutation rates and higher
recombination between similar, but not identical sequences, as well as resistance to certain DNA
methylating agents. Recently, a component of human MMR machinery, MutLα, has been shown to
display a latent endonuclease activity. The endonuclease active site appears to include a conserved
motif, DQHA(X)2E(X)4E, within the COOH-terminus of human PMS2. Substitution of the glutamic
acid residue (E705) abolished the endonuclease activity and mismatch-dependent excision in vitro.
Previously, we showed that the PMS2-E705K mutation and the corresponding mutation in
Saccharomyces cerevisiae were both recessive loss of function alleles for mutation avoidance in
vivo. Here, we show that mutations impacting this endonuclease motif also significantly affect MMR-
dependent suppression of homeologous recombination in yeast and responses to Sn1-type
methylating agents in both yeast and mammalian cells. Thus, our in vivo results suggest that the
endonuclease activity of MutLα is important not only in MMR-dependent mutation avoidance but
also for recombination and damage response functions.
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1. Introduction
DNA mismatch repair (MMR) is a conserved process, which repairs mismatches generated
during replication, by chemical damage and as “heteroduplex” intermediates during
recombination [1–4]. The MMR system also suppresses recombination between similar but
non-identical sequences, homeologous recombination [2,5]. Furthermore, in eukaryotes MMR
plays a role in responses to certain types of DNA damage [1,6–8], in particular by Sn1-type
DNA methylating agents [1,7–10]. Not surprisingly, MMR defects lead to a mutator phenotype,
which in humans and mice is associated with increased cancer susceptibility, most notably
hereditary nonpolyposis colon cancer (HNPCC) [1,11–15].
The minimal human MMR system has been reconstituted in vitro with purified recombinant
proteins, MutSα, MutLα, PCNA, RFC (the “clamp loader”), EXO1, RPA (HMGB1),
polymerase δ and DNA ligase I [16–18]. Similar to cell-free extracts, the in vitro repair is
directed by a strand discontinuity (a nick or gap) that can be located either 5′ or 3′ of the
mismatch. After recognition of mismatch, the mismatch-containing strand is degraded
exonucleolytically from the pre-existing nick or gap and subsequently the resulting single-
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stranded gap is resynthesized and ligated. One of the essential components of the MMR
machinery is MutLα, a heterodimer of MLH1 and PMS2 (Pms1 in yeast) [1–3,17,19]. Data
from in vitro studies indicate that MutLα is recruited to the heteroduplex DNA in a MutSα-
and ATP-dependent fashion and acts as an ATPase that coordinates protein conformational
changes which are important for MMR [20–23]. The in vitro studies further uncovered some
of the specific MutLα functions, including enhancement of mismatch-dependent excision and
participation in termination of excision upon mismatch removal [16–18].
Recently, biochemical studies of reconstituted human and yeast MMR have demonstrated a
latent endonuclease activity within MutLα [24, and personal communication, P. Modrich and
T. Kunkel]. This endonuclease activity is activated by MutSα bound to the mismatch, ATP,
PCNA and RFC. As a result, MutLα cleaves the discontinuous strand largely on the distal side
of the mismatch, thus generating a mismatch-containing DNA fragment spanned by two nicks.
Subsequently, this fragment is degraded by MutSα-activated EXO1. This endonuclease activity
of MutLα can account for the observation that EXO1, which only possesses 5′ –3′ activity, is
the only exonuclease required for the reconstituted in vitro MMR system, regardless of the
position of the initiating nick with respect to the mispair [24,25].
The endonuclease active site of human MutLα includes a conserved motif, DQHA(X)2E
(X)4E, within the COOH-terminus of PMS2 [24]. Substitution of either the aspartic (D699) or
the glutamic acid residue (E705) abolished the endonuclease activity and mismatch-dependent
excision [24]. We recently reported that the PMS2-E705K mutation and the corresponding
mutation pms1-E707K (previously referred to as pms1-E738K) in the budding yeast
Saccharomyces cerevisiae were both recessive mutations that crippled MMR-dependent
mutational avoidance in vivo [26]. Here, we address the importance of the conserved
endonuclease motif for additional MMR-dependent functions in budding yeast and mammalian
cells. We show that mutations within the endonuclease motif significantly affect MMR-
dependent suppression of homeologous recombination in yeast and responses to Sn1-type
methylating agents in both yeast and mammalian cells. In addition, these findings have
implications for the mechanisms of the damage response and recombination suppression by
MMR.
2. Materials and methods
2.1. Media and growth conditions
All media were prepared as described [27] except that synthetic media contained increased
leucine (60 mg/l). Growth and sporulation were at 30 °C. Sporulation of diploid cells and tetrad
dissections were performed as described [28,29].
SJR1392 and derivatives were grown in YEPGE (2% glycerol, 2% ethanol and supplemented
with 500 μg/ml adenine hemi-sulfate and 30 μg/ml tryptophan) [28]. For selection of His+
recombinants, S.D. medium lacking histidine was supplemented with 2% glycerol, 2% ethanol
and 2% galactose as carbon sources (SGGE-His) [28].
2.2. Strain constructions
All yeast strains are derivatives of a RAD5 CAN1 W303-1B unless otherwise noted (see Table
1) [30,31]. W303 derivatives (CAN1, his1-7, his7-2, hom3-10, pms1Δ, pms1-E707K and
rad52Δ) were described previously [29,32].
MGT1 disruption was constructed in haploid strains using a PCR-based gene disruption method
[33] utilizing TRP1 as a selective marker and the following primers, with upper-case letter
sequences complementary to MGT1 sequences and lowercase denoting selective marker
sequences: MGT1-H1 (5′-AAAAAAATTG AAAACGGTCG CATTTTTGAT
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CTAAATGGAC CAACGgagcagattgtactgag-3′) and MTG1-H2 (5′-
ACATAACTATTTCTTATGTTTATTTTCCTAAAATCCTTTATCCAA
tgtgcggtatttcacacc-3′). The disruption was confirmed by PCR.
The introduction of pms1Δ and pms1-E707K into SJR1392 were performed as described
previously [26,29].
2.3. Rate measurements and statistical analyses
The method of median was used to calculate the mutation rate [34]. Data from at least 20
independent cultures were used for each rate determination. Briefly, individual colonies from
SJR1392 and its derivatives were grown in YEPGE medium for 3 days [28]. Aliquots of
appropriate dilutions were plated onto synthetic complete medium (to determine viability of
the cells), medium lacking histidine and glucose, but containing galactose, ethanol and glycerol
(to select for homeologous recombinants) and medium lacking lysine (to select for homologous
recombinants). Statistical analyses were performed using Prism 3.0 Software (GraphPad
Software Inc.).
2.4. MNNG sensitivity by cytotoxicity and “spotting” assays
Sensitivity to a pulse of N-methyl-N′-nitro-N-nitrosoguanidine (MNNG; Sigma Chemical Co.,
St. Louis, MO) was determined by exposing exponentially growing yeast cells to varying
amounts of MNNG for 45 min followed by plating of appropriate dilutions on YPD. Surviving
colonies were counted after 3 days of incubation at 30 °C. For all strains, a plot of ln(survival
%) versus dose yielded a straight line and an LD50 was calculated as −ln(2)/α, where α is the
slope of the straight line.
For spotting assays, relevant yeast strains were grown overnight to saturation in YPD, serially
diluted (1:5) and spotted with a 48-prong replicator onto synthetic complete medium (CSM)
and CSM containing 0.35 μM MNNG plates and grown at 30 °C for 2 days.
For microscopy, logarithmatically growing liquid yeast cultures were exposed to 0.5 μM
MNNG for 45 min followed by washing and resuspending of the yeast culture in fresh media.
Aliquots of each culture were taken at appropiate time points. Cells were harvested by
centrifugation and fixed with methanol/acetic acid (3:1 ratio) for 0.5 h on ice and stained with
4′,6-diamino-2-phenylindole (DAPI, Accurate Biochemicals and Scientific Corp., Westbury,
NY) for 5 min at room temperature. Images were collected using a Zeiss Axiovert LSM5 Pascal
laser-scanning microscope. At least 100 cells were counted for each sample and each
experiment was done in duplicate.
2.5. Culturing of mouse cell lines and 6-tg treatment
Spontaneously-immortalized mouse embryonic fibroblast (MEF) cell lines used in this study
were derived from Pms2−/− C18 cells and grown as previously described [22,26,35].
Sensitivity to a “pulse” treatment of 6-tg (2-amino-6-mercaptopurine; Sigma Chemical Co.)
was determined by exposing exponentially growing cells to different concentrations of 6-tg
diluted into complete medium. Following a 24 h treatment at 37 °C, cells were rinsed once
with 5 ml of PBS and refed with complete medium. After 8 days, cell colonies were fixed in
30% ethanol 50% methanol, stained with 0.25% methylene blue and counted. For each dose,
three 100-mm plates were analyzed, seeded with either 300, 600 or 1000 cells. Each cell line
was tested in three independent experiments, and the colony-forming units (CFUs) at each dose
were averaged. For all strains, a plot of ln(survival%) versus dose yielded a straight line and
an LD50 was calculated as −ln(2)/α, where α is the slope of the straight line.
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2.6. Western blot analysis
Whole cell lysates from cultured cells were prepared and 50 μg of total cellular protein were
used for Western blot analysis as described previously [26,35]. hPms2 and mMsh6 proteins
were detected with monoclonal antibodies A16-4 and clone 44, respectively (BD Pharmingen).
3. Results and Discussion
Recent in vitro studies suggest that the endonuclease active site of human MutLα includes a
conserved motif, DQHA(X)2E(X)4E [24], within the MLH1-interaction domain of PMS2 (Fig.
1a, [36]). Substitution of the first glutamic acid residue (E705) abolishes the endonuclease
activity of human MutLα [24]. However, this substitution does not detectably affect either
yeast Pms1/Mlh1 or human PMS2/MLH1 interactions, the stability of Pms1 or PMS2 [26] or
interaction of MutLα with MutSα on a mismatch (personal communication, P. Modrich and
T. Kunkel). Nevertheless, we cannot exclude the possibility that this substitution might affect
other functions of MutLα such as interactions with unknown proteins. Our previous in vivo
studies showed that the E705K mutation in human PMS2 and the corresponding mutation
E707K in the PMS1 gene of S. cerevisiae were both recessive loss of function mutations for
MMR spellchecker activity [26]. Please note that in contrast to our previous report [26], we
now designate the relevant glutamic acid as residue 707 in accordance with the Stanford S.
cerevisiae data base. Here, we have addressed the importance of this conserved endonuclease
motif for additional MMR-dependent functions in budding yeast and mammalian cells.
3.1. pms1-E707K cripples MMR of different types of mispairs
Our previous study using a single mutation reporter (i.e., hom3-10) showed that the pms1-
E707K allele elevated −1 bp frameshifts to a level similar to a pms1Δ strain [26]. To gain
additional insight into the role of the endonuclease motif for MMR-dependent mutation
avoidance in yeast, we measured mutation in the pms1-E707K strain using four different
mutator assays [29]: forward mutation to canavanine-resistance at CAN1 that reports multiple
types of mutations, his1-798 (his1-7) reversion that reports base substitution (intragenic
suppressor) mutations, his7-2 reversion that reports +1 bp frameshifts in a run of 7A/T bp and
hom3-10 reversion that reports −1 bp frameshifts in a 7A/T run. Previous work demonstrated
that elevation of mutation in each assay in a pms1Δ strain can be visualized by increased number
of papillae on the appropriate selective media (Fig. 1b). As shown in Fig. 1b, the number of
papillae observed with the pms1-E707K strain was similar to pms1Δ in each assay. Therefore,
these results suggest that the endonuclease activity of MutLα is required for the repair of a
variety of mispairs.
3.2. pms1-E707K impacts the suppression of homeologous recombination
The role of MMR proteins in the suppression of homeologous recombination is well-
established in yeast, although the mechanism of suppression, including the role of MutLα, is
not clear [2,5]. To address whether the endonuclease activity of MutLα is important for
suppression of homeologous recombination, the pms1-E707K allele was introduced into the
PMS1 locus of a haploid yeast strain (SJR1392), which contains reporters that measure rates
of homeologous versus homologous recombination between inverted repeats [28]. We
measured the rates of homeologous recombination and homologous recombination by selecting
for inversion events that reconstitute full-length HIS3 and LYS2 genes, respectively. As shown
in Table 2, pms1Δ significantly increased the homeologous recombination rate, without
elevating homologous recombination. Normalized to homologous recombination, the increase
in the homeologous recombination was 24-fold in the pms1Δ mutant relative to PMS1.
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Similarly, pms1-E707K elevated the homeologous recombination rate by 8-fold relative to the
wild type. These results suggest that the endonuclease activity of yeast MutLα contributes to
the suppression of homeologous recombination.
Genetic requirements of suppression of yeast homeologous recombination have been examined
in great detail [2,5]. In particular, the suppressive role of MutLα seems less than that of
MutSα, because msh2Δ has a greater “elevating” effect on homeologous recombination than
either pms1Δ or mlh1Δ [37–39]. Therefore, mismatch binding/recognition may be sufficient
to trigger some level of recombination suppression in yeast. Although the exact role of
MutLα in homeologous recombination suppression is unknown, our results with the pms1-
E707K allele suggest that the endonuclease activity of MutLα is important. It is interesting to
note that the effect of pms1Δ allele on homeologus recombination appears to be greater than
the pms1-E707K allele. Therefore, MutLα appears to contribute to the suppression of
homeologous recombination by both endonuclease-dependent and -independent actions. We
suggest that the endonuclease-dependent contribution may reflect events containing
mismatched hDNA intermediates in which a single strand interruption 3′ to the mismatch(es)
provides an entry point for MMR-mediated suppression.
3.3. pms1-E707K (PMS2-E705) compromises the MMR-dependent DNA damage responses
in yeast and mammalian cells
In mammalian cells, MMR also participates in cytotoxic and cell cycle arrest responses to
certain classes of DNA damaging agents, most notably Sn1-type methylating agents [1,7–10].
Mammalian cells deficient in MMR show increased resistance to the cytotoxic effects of Sn1-
type methylating agents, such as nitrosoguanidine (MNNG) and the methylation mimetic drug,
6-thioguanine (6-tg) [8,40–42]. Recently, a similar MMR-dependent response was
demonstrated in yeast cells that were defective in both homologous recombination (rad52Δ)
and the methylguanine methyltransferase (mgt1Δ) [43]. This is illustrated in Fig. 2a and b,
which shows that whereas a rad52Δ mgt1Δ strain was highly sensitive to MNNG, the MMR
defective rad52Δ mgt1Δ pms1Δ strain was resistant.
To ask whether the endonuclease activity of MutLα is required for the damage response
pathway in yeast, we compared the cytotoxic responses of the rad52Δ mgt1Δ, rad52Δ mgt1Δ
pms1Δ and rad52Δ mgt1Δ pms1-E707K strains to MNNG. As shown in Fig. 2a, even at
relatively low doses, the rad52Δ mgt1Δ pms1-E707K strain displayed a level of resistance to
MNNG similar to that observed for rad52Δ mgt1Δ pms1Δ. This finding was further confirmed
by calculating the LD50 values(i.e., 50% survival) for each strain at a range of MNNG doses.
Whereas the LD50 of rad52Δ mgt1Δ strains was 0.25 μM, the LD50 of the rad52Δ mgt1Δ
pms1Δ and rad52 mgt1Δ pms1-E707K strains were 1.8 and 1.5 μM, respectively. These
observations suggest that the endonuclease activity of yeast MutLα is required for the cytotoxic
response to Sn1-type methylating agents.
In cultured mammalian cells, MMR-dependent responses to Sn1-type methylating agents are
associated with G2 cell cycle arrest [8,35,44]. To determine whether yeast show a similar cell
cycle arrest, we microscopically monitored logarithmically growing rad52Δ mgt1Δ, rad52Δ
mgt1Δ pms1Δ and rad52Δ mgt1Δ pms1-E707K strains following treatment with 0.5 μM
MNNG, a concentration that results in ~ 70% killing of the rad52Δ mgt1Δ cells with little effect
on either the rad52Δ mgt1Δ pms1Δ or rad52Δ mgt1Δ pms1-E707K strain (see Fig. 2b). Cells
were harvested at various times, fixed and stained with DAPI to visualize nuclear morphology.
Within 2 h of MNNG treatment, the rad52Δ mgt1 Δ cells accumulated with a nuclear and
budding morphology characteristic of G2/M arrested yeast (see Fig. 3). In contrast, rad52Δ
mgt1Δ pms1Δ and rad52Δ mgt1Δ pms1-E707K cells both grew normally in MNNG. These
results indicate that the response to MNNG in yeast is associated with a G2/M arrest, consistent
with observations in mammalian cells.
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Previous studies showed that Pms2-null kidney [45] and mouse embryonic fibroblasts cells
(Buermeyer and Liskay, unpublished results) were resistant to the cytotoxic effects of 6-
thioguanine (6-tg), a Sn1-type methylation mimetic drug [46,47]. Therefore, we determined
the colony-forming ability of Pms2−/− null mouse embryonic fibroblasts (MEF) stably
expressing empty vector, wild type hPMS2 or hPMS2-E705K after 24 h exposure to different
concentrations of 6-tg (Fig. 4a). Two cell lines that expressed hPMS2 at different levels were
highly sensitive to 6-tg relative to the Pms2-null cell lines (Fig. 4, compare LD50 of 0.28 μM
6-tg for hPMS2 lines versus LD50 of 1.33 μM 6-tg for the Pms2-null), indicating that expression
of wild type Pms2 within this range is sufficient for the normal response to 6-tg. Similar to the
Pms2-null cells, cells expressing hPMS2-E705K were highly resistant to 6-tg, showing an
LD50 of 1.31. These results suggest that, similar to budding yeast, the endonuclease activity
of human MutLα is required for the MMR-dependent DNA damage response to Sn1-type
methylating agents.
Two contrasting, but not mutually exclusive models, have been proposed for the MMR-
dependent response to Sn1-type methylating agents in mammalian cells [3,10,42,48]. The first
model, termed “futile repair”, invokes repeated cycles of MMR on O6meG/T formed during
replication. Repeated cycles fail to remove damage in the template strand that in turn may lead
to double strand breaks [8]. In contrast, in the “direct signaling” model MMR protein
complexes bound to O6meG/T mispairs act as direct sensors to signal for cell cycle checkpoint
arrest and/or apoptosis [3,10,42,48].
Support for the futile cycling model comes from several studies including in vitro results
showing reiterative MMR excision cycles on O6meG/T containing plasmid substrates [49]. In
contrast, support for direct signaling comes in part from a “separation-of-function” allele of
mouse Msh6 that impacts spellchecking with little or no effect on the MMR-dependent DNA
damage response [50]. The signaling model is also supported by the demonstration that
MutSα/MutLα complexes are required for the recruitment of ATR–ATRIP to methylation
damage sites (O6meG/T mispairs) and subsequent ATR kinase activation [51]. The results
reported here appear consistent with futile repair because a defective endonuclease can be
expected to impede repeated cycles of MMR-dependent excision.
In summary, by altering a conserved motif in both yeast Pms1 and human PMS2, we asked
whether the endonuclease of yeast and human MutLα is important for several MMR-dependent
functions. We draw several conclusions from our study. First, the MutLα endonuclease of yeast
is required for the repair of a variety of different types of mispairs. Second, the MutLα
endonuclease of yeast contributes to the suppression of homeologous recombination. And third,
in both yeast and mammalian cells, the endonuclease activity of MutLα is required for the
MMR-dependent response to DNA methylation damage.
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(a) Pms1/2 domains and location of E707/E705. The ATPase domain, the Mlh1-interacting
domain and a motif critical for MutLα endonuclease activity are indicated by hatched, black
and grey boxes, respectively. The “mutated” E707/E705 residue is indicated by an arrow.
Numbers correspond to the amino acid position in the protein in accordance with the current
data bases. (b) Papillation phenotypes of the wild type, pms1Δ, pms1-E707K strains. The
relative mutator effects in wild type, pms1Δ, pms1-E707K strains were detected by monitoring
forward mutation at CAN1 (multiple types of mutations) vs. reversion at his1-7 (intragenic
missense suppressor mutations), his7-2 (+1 bp frameshifts in a stretch of 7A/T bp) or
hom3-10 (−1 bp frameshifts in a stretch of 7A/T bp) by replica plating onto appropriate selective
media. It should be noted that pms1Δ strains contain ade2-1 that results in solid red colored
papilliae, whereas pms1-E707K strains contain a ade2-9G (+1 bp frameshift in a stretch of 9G/
C bp) reporter that gives rise to red/white papilliae due to DNA polymerase slippage in the 9
G/C run.
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MNNG-induced killing of rad52Δ mgt1Δ, rad52Δ mgt1Δ pms1Δ and rad52Δ mgt1Δ pms1-
E707K yeast strains: (a) comparison of MNNG responses for wild type, mgt1Δ, rad52Δ and
pms1 mutants in combinations as measured by a serial dilution spot test. Late-log phase cells
were spotted on CSM and CSM + 0.35 μM MNNG plates at 5-fold serial dilutions as described
in the Section 2. (b) MNNG survival curves. mgt1Δ (■), rad52Δ mgt1Δ pms1Δ (▲), rad52Δ
mgt1Δ pms1-E707K (●) and rad52Δ mgt1Δ (♦) strains were exposed for 45 min to increasing
amounts of MNNG and survival was determined. Error bars represent standard error of the
mean. LD50 values for mgt1Δ, rad52Δ mgt1Δ pms1Δ, rad52 mgt1Δ pms1-E707K and
rad52Δ mgt1Δ strains were 9.7, 1.8, 1.5 and 0.25 μM MNNG, respectively.
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Cell cycle arrest phenotype of rad52Δ mgt1Δ mutant strains after exposure to MNNG. After
45 min exposure to 0.5 μM MNNG, cells from rad52Δ mgt1Δ, rad52Δ mgt1Δ pms1Δ and
rad52Δ mgt1Δ pms1-E707K cultures were collected every hour, fixed and stained with DAPI:
(a) after 2 h, rad52Δ mgt1Δ accumulated as large-budded cells with a single nucleus and (b)
quantification of cell cycle arrest after MNNG exposure. Distribution of cells from rad52Δ
mgt1Δ, rad52Δ mgt1Δ pms1Δ and rad52Δ mgt1Δ pms1-E707K cultures after exposure to
MNNG are depicted as percentages. Cells were divided into categories as cells with no buds,
small buds, large buds and divided cells. For each time point, at least 100 cells were counted
in two separate experiments.
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Survival of MEFs after treatment with 6-tg: (a) 8 days after a 24 h exposure to 6-tg, CFU were
determined for Pms2-deficient (♦), hPMS2-E705K expressing (▲) and low and high hPMS2-
expressing (■, ●) MEF cells. Error bars represent standard error of the mean. LD50 values were
1.33, 1.31, and 0.28 μM 6-tg for Pms2-deficient, hPMS2-E705K expressing and low hPMS2-
expressing MEF cells, respectively. (b) Expression of hPMS2 and hPMS2-E705K in stably-
transfected MEFs. To determine the level of hPMS2-E705K vs. wild type hPMS2 expression
levels in MEFs, whole cell lysates were prepared and compared by Western analysis.
Endogenous Msh6 expression was used to normalize hPMS2 expression.
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Table 1
Strains used in this study
Strain Genotype Source
W1558-4A MATαade2-1 CAN1 his3-11,15 leu2-3,112 trp1-1 ura3-1 RAD5 [31]
NEY915 W1558 mgt1::TRP1 This study
NEY978 W1588 mgt1::TRP1 rad52::HIS5 This study
NEY981 W1588 mgt1::TRP1 rad52::HIS5 pms1::TRP1 This study
NEY1012 W1588 mgt1::TRP1 rad52::HIS5 pms1-E707K This study
NEY524 MATαade2-1 CAN1 his1-7 hom3-10 leu2-3,112 trpl-1 ura3-1 RAD5 [29]
NEY442 NEY524 pms1::TRP1 [29]
NEY1349 NEY524 pms1-E707K ade2-9G This study
NEY570 MATαade2-1 CAN1 his7-2 hom3-10 leu2-3,112 trp1-1 ura3-1 RAD5 [29]
NEY662 NEY524 pms1::TRP1 [29]
NEY1350 NEY524 pms1-E707K ade2-9G This study
SJR1392 MATαade2-101oc his3Δ 200 lys2Δ RV::hisG trp5 Δ::kan ura3(Nhe)-
[HIS3::intron::cβ2/cβ7(91%)]-ura3(Nhe) leu2(K)-[lys2Δ3′-lys2Δ5′]-LEU2
Sue Jinks-Robertson
NEY644 SJR1392 pms1::URA3 This study
NEY1351 SJR1392 pms1-E707K This study
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Table 2
Effect of pms1-E707K on homeologous recombination
Strain Homologous (Lys+, × 10−6) Homeologous (His+, × 10−6) His+/Lys+
PMS1 5.0 (4.1–5.9) 0.07 (0.051–0.089) 0.014 [1]
pms1Δ 7.4 (6.2–8.5) 2.42 (1.8–3.0) 0.33 [24]
pms1-E707K 12.6 (8.6–17) 1.35 (1.1–1.6) 0.11 [8]
( ) 95% Confidence intervals; [ ] fold effects relative to PMS1.
DNA Repair (Amst). Author manuscript; available in PMC 2008 May 5.
